Skip to content
ETopical – Lifestyle
Home
Sample Page
Author:
Apotex Inc.
Apotex Strengthens Osteoporosis Care in Canada with Health Canada’s Approval of DENOZA™, a Denosumab Biosimilar
April 7, 2026
Apotex announces leadership changes
March 30, 2026
Apotex Expands Canadian Ophthalmology Portfolio with Health Canada’s Approval of CLOBIVIS™ (Clobetasol Propionate Ophthalmic Suspension, 0.05%)
March 25, 2026
←
Previous Page
1
2